Diana C Grootendorst
Overview
Explore the profile of Diana C Grootendorst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1552
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Minderhout H, Joosse M, Grootendorst D, Schalij-Delfos N
Acta Ophthalmol
. 2021 Oct;
100(4):454-461.
PMID: 34672100
Purpose: To compare the refractive outcome and residual accommodation with respect to various degrees of iris and skin pigmentation in hypermetropic children using 2 drops of cyclopentolate 1% (C + ...
2.
van Minderhout H, Joosse M, Grootendorst D, Schalij-Delfos N
Strabismus
. 2019 Jun;
27(3):127-138.
PMID: 31234691
: To evaluate the refractive outcome and influencing factors following atropine 0.5% eye-drops applied twice daily during 2 ½ days at home and two drops of cyclopentolate 1% (C+C) and...
3.
Van Woerden G, van den Brand C, Den Hartog C, Idenburg F, Grootendorst D, van der Linden M
Int J Emerg Med
. 2016 Feb;
9(1):4.
PMID: 26860533
Background: The most common complaint of patients attending the emergency department (ED) is pain, caused by different diseases. Yet the treatment of pain at the ED is suboptimal, and oligoanalgesia...
4.
van Minderhout H, Joosse M, Grootendorst D, Schalij-Delfos N
BMJ Open
. 2015 Dec;
5(12):e008798.
PMID: 26700273
Objectives: To investigate the presence, nature and relationship to age, sex, ethnicity and body mass index (BMI) of adverse reactions following routine cycloplegic eye drops in children. Design: Prospective observational...
5.
Moret K, Grootendorst D, Beerenhout C, Kooman J
NDT Plus
. 2015 May;
2(4):334-5.
PMID: 25984033
No abstract available.
6.
Van der Linden N, van der Linden M, Richards J, Derlet R, Grootendorst D, van den Brand C
Eur J Emerg Med
. 2015 Apr;
23(5):337-43.
PMID: 25831039
Background: The impact of delays in emergency department (ED) care has not been described in European countries where ED crowding is not universally recognized. The aim of this study was...
7.
Westland G, Grootendorst D, Halbesma N, Dekker F, Verburgh C
J Ren Nutr
. 2014 Dec;
25(3):265-70.
PMID: 25455422
Objective: To examine the prevalence of and risk factors for malnutrition at the start of specialized predialysis care. Design: The present analysis was performed on cross-sectional data collected at inclusion...
8.
Stiksma J, Grootendorst D, van der Linden P
Clin Colorectal Cancer
. 2014 Dec;
13(4):239-44.
PMID: 25442815
Background: Carcinoembryonic antigen is the commonly used tumor marker in patients with colorectal cancer, and CA 19-9 might be an additional marker. The aim of this retrospective study was to...
9.
Rozeman A, Ottolini T, Grootendorst D, Vogels O, Rijsman R
J Clin Sleep Med
. 2014 Aug;
10(8):893-6.
PMID: 25126036
Study Objective: A variety of sensory stimuli relieve restless legs syndrome symptoms. Because systematic evaluations of sensory stimulation in restless legs syndrome are largely lacking, we performed a randomized crossover...
10.
de Goeij M, Meuleman Y, van Dijk S, Grootendorst D, Dekker F, Halbesma N
Nephrol Dial Transplant
. 2014 Feb;
29(7):1391-8.
PMID: 24516235
Background: In predialysis patients, the optimal treatment choices for controlling haemoglobin (Hb) are unknown, because targeting high Hb levels has negative effects--poorer survival--but possible positive effects as well--better health-related quality...